Pro-inflammatory myeloid cells and T cells

Pro-inflammatory myeloid cells and T cells represent a coordinated network of immune cells that drive the inflammatory response in various disease states. Myeloid cells, such as macrophages and dendritic cells, act as innate sensors that produce pro-inflammatory cytokines like TNF-alpha and IL-6 (PubMed, 2021). These cells also present antigens to T cells, facilitating their differentiation into effector subsets like Th1 and Th17 cells, which further propagate inflammation (Nature Reviews Immunology, 2020). This cellular axis is a primary driver of tissue damage in autoimmune diseases and chronic inflammatory conditions (NIH, 2023). In oncology, the interaction between these cells within the tumor microenvironment can either support or hinder anti-tumor immunity (Journal of Clinical Investigation, 2022). Because this target represents a cellular population rather than a single molecular entity, therapeutic targeting involves a variety of drugs that inhibit specific cytokines, surface receptors, or intracellular signaling pathways to modulate immune activity (StatPearls, 2023).

Other names

Inflammatory myeloid and T cell populationsActivated immune cell axisMyeloid-T cell inflammatory network

Inhibition of pro-inflammatory signaling and cellular activation through the blockade of cytokines, costimulatory molecules, or intracellular signaling cascades.